Effect of Ondansetron, Metoclopramide and Dexamethasone on Post Operative Nausea Vomiting after strabismus surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012051138N4

Enrollment

111

Registered

2011-01-05

Start date

2007-11-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

strabismus. H50

Interventions

Intervention 1: Group A (ondansetron) 0.1mg/kg IV 30 minutes before ending surgery. Intervention 2: Group B ( metoclopramide) 0.15mg/kg IV 30 minutes before ending surgery. Intervention 3:

Treatment - Drugs

Group A (ondansetron) 0.1mg/kg IV 30 minutes before ending surgery

Group B ( metoclopramide) 0.15mg/kg IV 30 minutes before ending surgery

Group C ( dexamethasone) 0.15mg/kg IV at the start of surgery

Eligibility

Sex/Gender

All

Age

2 Years to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- The patients candidates for strabismus surgery between 2-15 years 2- physical class status(ASA) I-II Exclusion criteria: 1-Historyof GI problems 2-History of known drug sensitivity to drugs used in study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Frequency of nausea and vomiting. Timepoint: In the first hour (recovery period) 1to 6 , 6 to 12 , 12to24 hours post – operation. Method of measurement: Questionnair.	—

Secondary

Measure	Time frame
Frequency of nausea and vomiting treatment. Timepoint: In the first hour (recovery period) 1to 6 , 6 to 12 , 12to24 hours post – operation. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sudabeh Haddadi

Guilan University of Medical Sciences

So_haddadi@gums.ac.ir+98 13 1222 5242

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026